These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 144056)

  • 1. Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status.
    Ugazio AG; Jayakar SD; Marcioni AF; Duse M; Monafo V; Pasquali F; Burgio GR
    Eur J Pediatr; 1977 Oct; 126(3):139-46. PubMed ID: 144056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological features of Down's syndrome: a review.
    Nespoli L; Burgio GR; Ugazio AG; Maccario R
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():543-51. PubMed ID: 8124000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiency in Down's syndrome. Titres of "natural" antibodies to E. coli and rabbit erythrocytes at different ages.
    Ugazio AG; Lanzavecchia A; Jayakar S; Plebani A; Duse M; Burgio GR
    Acta Paediatr Scand; 1978 Nov; 67(6):705-8. PubMed ID: 152559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down's syndrome and hepatitis: an evaluation of carrier status.
    Dicks JL; Dennis ES
    J Am Dent Assoc; 1987 May; 114(5):637-9. PubMed ID: 2955013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome: problems of immunodeficiency.
    Ugazio AG
    Hum Genet Suppl; 1981; 2():33-9. PubMed ID: 6218139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of antithyroid antibodies in Down's syndrome.
    Schmidt BJ; Piva S; Schalch AL; Ortega C; Sousa MM; Torres DB; Krynski S
    Arq Neuropsiquiatr; 1978 Dec; 36(4):312-5. PubMed ID: 156017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
    Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
    Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predisposition of Down syndrome to chronic infection with the hepatitis B virus].
    Rua Armesto MJ; Ramírez Marín V; Onaindia Ercoreca MT; García Aguado J; Ruiz Moreno M
    An Esp Pediatr; 1993 Jun; 38(6):529-31. PubMed ID: 8368682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities.
    Rabinowe SL; Rubin IL; George KL; Adri MN; Eisenbarth GS
    J Autoimmun; 1989 Feb; 2(1):25-30. PubMed ID: 2526634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency in Down's syndrome: low levels of serum thymic factor in trisomic children.
    Duse M; Brugo MA; Martini A; Tassi C; Ferrario C; Ugazio AG
    Thymus; 1980 Dec; 2(3):127-31. PubMed ID: 6451065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australia antigen in Down's syndrome patients with Robertsonian translocation.
    Tevaluoto-Aarnio M; Hongell K
    Med Biol; 1974 Feb; 52(1):70-1. PubMed ID: 4283654
    [No Abstract]   [Full Text] [Related]  

  • 18. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of AFP in chronic carriers of HBsAg with Down's syndrome].
    Carrascosa D; Casado A; Ramírez MV; Sáez J
    Aten Primaria; 1995 Sep; 16(5):296-7. PubMed ID: 7578846
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
    Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
    Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.